Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial
Recruiting · NCT06989892 · Interventional (participants receive a specific treatment) · Lead sponsor: Navamindradhiraj University
View the official record on ClinicalTrials.gov →Interventions studied
High-flux dialyzer (Elisio 19H)Super High-flux dialyzer (Elisio 19HDx)
What this trial is about
Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- ESKD patients who have sepsis condition with high interleukin-6 (IL-6 \> 50 pg/ml)
Exclusion criteria
- Patients who needed dialysis with continuous kidney replacement therapy, vulnerable patient, include pregnant woman, patient who expected to pass away within the 24 hours.
- Patients who have the history of allergic dialyzer reaction to dialyzer which used in this trial.
Where it is running
1 location listed.
- Navamindhradhiraj university - Dusit, Bangkok, Thailand